1. Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;
2. Transponics, Essex Junction, VT;
3. ConverGene LLC., Cambridge, MD;
4. Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Rockville, MD;
5. CCR-SF Bioinformatics Group and
6. Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD; and
7. Center for Retrovirus Research, The Ohio State University, Columbus, OH